COVID 19 : Seroprevalence Study of Anti SRAS-CoV-2 Antibodies in GHT Employees in Haute Bretagne (AntiCoV-HB) (AntiCoV-HB)
Coronavirus
About this trial
This is an interventional diagnostic trial for Coronavirus focused on measuring Covid 19, SRAS-CoV-2
Eligibility Criteria
Inclusion Criteria:
- Employees of voluntary establishments of GHT Haute-Bretagne
- Employees over the age of 18
- Having signed a free, informed and written consent.
Exclusion Criteria:
- Employees subject to legal protection (safeguard of justice, guardianship, curatorship)
Sites / Locations
- CENTRE HOSPITALIER de VITRE_ Saint Jean (La Guerche)
- Centre Hospitalier de Fougeres
- Centre Hospitalier Grand Fougeray
- Centre Hospitalier de La Roche Aux Fees
- Centre Hospitalier Montfort-Sur-Meu
- Centre Hospitalier de Redon Carentoir
- Chu Rennes
- Centre Hospitalier St Meen Le Grand
- CENTRE HOSPITALIER VITRE_Simone Veil
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Other
Other
Other
Other
Seroprevalence survey
Validation test of the NG test survey
Detailed Survey
Prevalence monitoring (2 population samples)
NG Test + short self-questionnaire (except validation survey and detailed survey)
Blood test + NG test + detailed self-questionnaire
NG test + self-questionnaire complementary to the short questionnaire
Participants having presented a certain or probable COVID: acts of the validation test survey, + follow-up questionnaire,+ blood test + NG test, on D30 and D90 Others Participants : drawn by lot: acts of the seroprevalence survey, + follow-up questionnaire + NG test, on D90